文献速递瓣膜外科

右微创开胸与胸骨正中切开二尖瓣修复的21年单中心对比研究

Mitral valve repair by right minithoracotomy compared with sternotomy: 21-year single-center experience.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-01-22

该单中心回顾性研究纳入2001至2022年976例退行性二尖瓣反流行二尖瓣修复患者,按手术入路分为胸骨正中切开组437例与右微创开胸组539例。匹配队列中右微创开胸组手术时间更短、住院时间更短,两组院内死亡率均为0%,长期全因死亡率和二尖瓣相关再手术累积发生率相当,右微创开胸组左房大小和三尖瓣反流压差下降更明显。

要点

  • 右微创开胸二尖瓣修复早期安全性与快速恢复优于胸骨正中切开。
  • 两种入路长期二尖瓣相关再手术累积发生率相当,修复耐久性相似。
  • 右微创开胸组左房大小和三尖瓣反流压差下降更明显。

核心结论

  • 与胸骨正中切开相比,右微创开胸二尖瓣修复提供良好的早期安全性和更快的恢复。
  • 以二尖瓣相关再手术累积发生率反映的长期修复耐久性与胸骨正中切开相似。
  • 生存估计需结合两组随访时长不同来解读。
  • 在有经验的中心,微创二尖瓣修复是退行性二尖瓣反流的可行替代方案。

研究设计与样本

  • 单中心回顾性分析,纳入2001至2022年976例(平均年龄60±13岁)行二尖瓣修复伴或不伴同期手术的患者。
  • 按手术入路分为胸骨正中切开组(n=437)和右微创开胸组(n=539)。
  • 评估早期结局、长期死亡率、二尖瓣相关再干预累积发生率及系列超声心动图变化。

主要发现

  • 胸骨正中切开组中位临床随访12.8(8.4-16.6)年,右微创开胸组4.9(3.1-7.1)年。
  • 匹配队列中右微创开胸组手术时间更短、住院时间更短。
  • 两种入路院内死亡率均为0%。
  • 两种入路长期全因死亡率和二尖瓣相关再手术累积发生率相当。
  • 混合效应模型显示两种入路均实现持久的二尖瓣反流减轻和有利的左心室重构,右微创开胸组左房大小和三尖瓣反流压差下降更明显。

临床怎么用

  • 在有经验的中心,右微创开胸二尖瓣修复可作为退行性二尖瓣反流的可行替代入路。
  • 选择右微创开胸入路时需结合中心经验和患者个体情况,关注其早期恢复优势。
  • 解读长期生存比较时应考虑两组随访时长不同。

局限性

  • 单中心回顾性分析。
  • 两组随访时长不同,胸骨正中切开组中位随访12.8年,右微创开胸组4.9年。
  • 生存估计需结合随访时长差异解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Right minithoracotomy mitral valve surgery has become a minimally invasive alternative to median sternotomy, although long-term outcomes remain incompletely defined. This study compared early and late outcomes of the 2 approaches in patients with degenerative mitral regurgitation. METHODS: A single-center retrospective analysis was performed of 976 patients (mean age 60 ± 13 years) who underwent mitral valve repair, with or without concomitant procedures, between 2001 and 2022. Patients were categorized by surgical approach: sternotomy (n = 437) or right minithoracotomy (n = 539). Early outcomes, long-term mortality, cumulative incidence of mitral-related reintervention, and serial echocardiographic changes were evaluated. RESULTS: Median (interquartile range) clinical follow-up was 12.8 (8.4-16.6) years in the sternotomy group and 4.9 (3.1-7.1) years in the minithoracotomy group. In the matched cohort, the minithoracotomy approach was associated with shorter operative time and reduced hospital stay. In-hospital mortality was 0% in both approaches. The long-term all-cause mortality and cumulative incidence of mitral-related reoperation were comparable between the approaches. The mixed-effect model indicated both approaches achieved durable mitral regurgitation reduction and favorable left ventricular remodeling, whereas minithoracotomy showed greater reductions in left atrial size and tricuspid regurgitation pressure gradient. CONCLUSIONS: Compared with sternotomy, right minithoracotomy mitral repair provided excellent early safety and faster recovery. Long-term repair durability, reflected by comparable cumulative incidence of mitral-related reoperation, was similar to sternotomy, whereas survival estimates should be interpreted in the context of differential follow-up duration. When performed at experienced centers, minimally invasive mitral valve repair represents a viable alternative for degenerative mitral regurgitation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kainuma S, Kawamoto N, Kakuta T, et al. Mitral valve repair by right minithoracotomy compared with sternotomy: 21-year single-center experience. J Thorac Cardiovasc Surg. 2026. PMID: 41580071. doi:10.1016/j.jtcvs.2026.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。